Erik van den Berg | CEO
Memo-Therapeutics AG

Erik van den Berg is the CEO of Memo Therapeutics AG, bringing over 25 years of industry experience and a proven track record in leadership and company growth. He is the former CEO of AM-Pharma and holds chairmanships in Step Pharma and TargED Therapeutics and was the co-founder and (executive) chairman of Lava Therapeutics and HeatMatrix Group. He has orchestrated over 20 transactions and partnerships, notably a $600 million alliance with Pfizer, a $290 million partnership with Kyowa Kirin, and has secured over $500 million in equity and debt financings for biotech firms from seed to IPO. Erik holds an MSc in Chemistry from the University of Utrecht and an MBA from Manchester Business School.